WashU Cardiology Forum: Educate. Innovate. Collaborate

Click here to Register. 

The Wash U Cardiology Forum is planned and implemented interprofessionally by cardiologists, advanced cardiology practice providers, and pharmacists. The activity is designed for cardiologists, advanced practice providers, and pharmacists, but may be of interest to primary care physicians and physician associates with an interest in cardiology. This Live activity will provide education through lectures, case presentations, panel discussions, interactive sessions, and open discussions. This activity will highlight best practices across general cardiology, electrophysiology, interventional cardiology, heart failure, global health, and valvular heart disease. The goal of this activity is to enhance knowledge, skills and strategy, performance and patient care. 

For additional information and questions please contact Heather De Gortari. 

1. Describe evidence based strategies for the prevention of heart disease, including hypertension and lipid management, and evaluate the appropriate use of nonstatin therapies in patients at risk for cardiovascular events.
2. Explain the role of coronary computed tomography angiography (CCTA) in the screening and risk assessment of coronary artery disease.
3. Cite how imaging guidance is used to optimize percutaneous revascularization in patients with coronary artery disease, including selection of lesions and assessment of procedural outcomes.
4. Identify emerging therapeutic strategies, including GLP1 receptor agonists and other novel agents, for managing cardiometabolic disease in patients with heart failure to improve clinical outcomes.
5. Evaluate current evidence and guideline recommendations regarding the timing of intervention for aortic stenosis, including considerations for treating patients before the onset of symptoms.
6. Restate the indications, types, and clinical applications of mechanical circulatory support in critically ill cardiac patients to improve hemodynamic stability and outcomes.
7. Summarize essential knowledge about the diagnosis, management, and long term care considerations of adults and children with congenital heart disease and incorporate into patient care plans.
8. Appraise the clinical indications, benefits, and limitations of left atrial appendage occlusion (LAAO) devices to determine which patients are most likely to benefit from this therapy.
9. Interpret recent advances in the diagnosis and treatment of transthyretin (ATTR) cardiac amyloidosis and apply strategies to optimize patient care and outcomes.
10. Review current applications of artificial intelligence in healthcare, including cardiovascular care, and evaluate its potential to enhance clinical decision making, workflow efficiency, and patient outcomes.

In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis and Meeting Achievements. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Credits Available for this Activity:

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 7.25 ANCC contact hours.

Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for a maximum of 7.25 knowledge-based contact hours (.725 CEUs) in states that recognize ACPE. Participants should only claim credit commensurate with the extent of their participation in the activity. Unique Universal Activity Number JA0000340-9999-26-009-L01-P. To be awarded credit, attendees must sign in, provide their NABP ePID number and date of birth.

Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 7.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

This meeting is conducted in accordance with the requirements of the Americans with Disabilities Act (ADA) and applicable regulations.
Individuals who require accommodations to participate are encouraged to submit a written request as early as possible, but no later than ten (10) business days prior to the seminar date, to allow sufficient time to arrange appropriate accommodations. Requests received after this deadline will be reviewed and a good faith effort will be made to provide reasonable accommodations to the extent feasible.

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Andrew M. Kates, MD
Washington University School of Medicine
St. Louis, MO

Course Director, Faculty

Grant or research support-Eidos Therapeutics Inc

Anubha Agarwal, MD, Cardiologist
WashU Med
St. Louis, MO

Faculty

Grant or research support-REMEDIUMONE PRIVATE LIMITED

Alan C. Braverman, MD
Alumni Endowed Professor in Cardiovascular Diseases; Professor of Medicine
Washington University School of Medicine
St. Louis, MO

Faculty

Nothing to disclose

Angela L. Brown, MD, FAHA, FACP
Dr
Washington University School of Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-Medtronic Inc (*)|Speakers Bureau-Not Found (*)|Speakers Bureau-Recor Medical (*)

Sharon Cresci, MD, Professor of Medicine
Washington University
St. Louis, MO

Faculty

Grant or research support-Imbria Pharmaceuticals|Other relevant financial or material interests-Bristol Myers Squibb Co/BMS (*)|Other relevant financial or material interests-Cytokinetics Inc (*)

Phil S. Cuculich, MD
Washington University School of Medicine
St. Louis, MO

Faculty

Grant or research support-Implicit Biosciences|Other relevant financial or material interests-Varian Medical Systems Inc|Royalties or Patent Beneficiary-Varian Medical Systems Inc

Nathan Frogge, MD
Washington University / Barnes-Jewish
St Louis, MO

Faculty

Nothing to disclose

Mark Gdowski, MD
St. Luke's Hospital
St. Louis, MO

Faculty

Nothing to disclose

Anne C. Goldberg, MD,
Professor of Medicine, Endocrinology, Metabolism and Lipid Research Division
Anne
St Louis, MO

Faculty

Grant or research support-89bio Inc|Grant or research support-Amgen Inc|Grant or research support-Arrowhead Pharmaceuticals|Grant or research support-Ionis Pharmaceuticals Inc|Grant or research support-Marea Therapeutics, Inc.|Grant or research support-Novartis Pharmaceuticals Corporation|Other relevant financial or material interests-Eli Lilly & Co|Other relevant financial or material interests-Esperion|Other relevant financial or material interests-Ionis Pharmaceuticals Inc|Other relevant financial or material interests-NewAmsterdam Pharma BV|Other relevant financial or material interests-Eli Lilly & Co (*)|Other relevant financial or material interests-Ionis Pharmaceuticals Inc (*)|Other relevant financial or material interests-NewAmsterdam Pharma BV (*)

Ali Javaheri, MD,
Washington University School of Medicine
St. Louis, MO

Faculty

Grant or research support-Bitterroot Bio (Relationship has ended)|Grant or research support-Alleviant|Grant or research support-Reprieve

Farhan Katchi, MD
Assistant Professor
Washington University School of Medicine / Cardiovascular Division
St. Louis, MO

Faculty

Grant or research support-Cleerly, Inc.|Grant or research support-Siemens Healthineers USA|Speakers Bureau-HeartFlow, Inc.|Grant or research support-Novartis Pharmaceuticals Corporation|Speakers Bureau-AGEPHA Pharma (*)

John M. Lasala, MD,
Professor of Medicine
Washington University School of Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-Abbott Diagnostics|Other relevant financial or material interests-Abiomed (*)|Other relevant financial or material interests-Boston Scientific Corporation|Other relevant financial or material interests-Cordis (*)|Other relevant financial or material interests-Shockwave Medical Inc (*)|Other relevant financial or material interests-W.L. Gore and Associates|Speakers Bureau-Abbott Diagnostics|Speakers Bureau-Abiomed (*)|Stocks or stock options, excluding diversified mutual funds*-Abiomed (*)|Grant or research support-JenaValve Technology

Thomas M Maddox, MD, SM
Washington University School of Medicine
St. Louis, MO

Faculty

Nothing to disclose

Adam May, MD
Washington University School of Medicine
Maryville, IL

Faculty

Other relevant financial or material interests-Abbott Diagnostics|Speakers Bureau-GE Healthcare Inc|Other relevant financial or material interests-Abbott Diagnostics (*)|Speakers Bureau-GE Healthcare Inc (*)

Deana Mikhalkova, MD
St Louis University SSM
St Louis, MO

Faculty

Nothing to disclose

Ugonna Nwankwo, MD
Associate Professor
Wash U Medicine
St. Louis, MO

Faculty

Nothing to disclose

Sumanth D Prabhu, MD, FACC
Professor and Chief, Cardiovascular Division
Washington University School of Medicine
St. Louis, MO

Faculty

Grant or research support-Cardurion Pharmaceuticals|Grant or research support-Dalcor Pharmaceuticals Canada Inc.|Grant or research support-Novo Nordisk AS

Nancy K Sweitzer, MD, PhD, Professor of Medicine
Doctor
Washington University in St Louis
St Louis, MO

Faculty

Grant or research support-Insignis Therapeutics Inc.|Other relevant financial or material interests-Cellphire Inc|Other relevant financial or material interests-Cellular Logistics (*)|Other relevant financial or material interests-Corteria Pharmaceuticals (*)|Other relevant financial or material interests-Corvia Biomedical (*)|Other relevant financial or material interests-Salubris Biotherapeutics|Other relevant financial or material interests-Sardocor|Royalties or Patent Beneficiary-Cellular Logistics (*)|Other relevant financial or material interests-Cellphire Inc (*)|Other relevant financial or material interests-Salubris Biotherapeutics (*)|Other relevant financial or material interests-Sardocor (*)

Joshua D. Mitchell, MD, MSCI, FACC, FIC-OS
Associate Professor of Medicine
Washington University in St. Louis
St. Louis, MO

Faculty, Other Planning Committee Member

Grant or research support-Abbott Diagnostic Scarborough Inc|Grant or research support-Alexion Pharmaceuticals Inc|Grant or research support-Alnylam Pharmaceuticals Inc|Grant or research support-AstraZeneca AB (Sweden)|Grant or research support-Bayer HealthCare Pharmaceuticals|Grant or research support-Bristol Myers Squibb Co/BMS|Grant or research support-Eidos Therapeutics Inc|Grant or research support-Ionis Pharmaceuticals Inc|Grant or research support-Jazz Pharmaceuticals|Grant or research support-Novo Nordisk AS|Grant or research support-Preventice Solutions|Other relevant financial or material interests-Alnylam Pharmaceuticals Inc (*)|Other relevant financial or material interests-AstraZeneca (*)|Other relevant financial or material interests-BridgeBio Pharma (*)|Other relevant financial or material interests-Pfizer Inc (*)

Nishat Quader, MD
washington university - st louis
St. Louis, MO

Faculty, Other Planning Committee Member

Grant or research support-Kardigan, Inc

Anupama K Rao, MD, FACC, FSCMR
Associate Professor of Medicine/Director Cardiac Imaging- St Luke's
Rush University/St Luke's Hospital
Clayton, MO

Faculty, Other Planning Committee Member

Nothing to disclose

Prashanth Thakker, MD,
Assistant Professor
Washington University/Barnes Jewish Hospital
Saint Louis, MO

Faculty, Other Planning Committee Member

Consulting Fee-ABIOMED, INC.|Consulting Fee-Phillips|Consulting Fee-AMGEN (Any division)|Consulting Fee-Biotronik|Consulting Fee-MEDTRONIC|Consulting Fee-Shockwave

Amanda Verma, MD
Associate Professor of Medicine
Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine
St Louis, MO

Faculty, Other Planning Committee Member

Grant or research support-Kiniksa Pharmaceuticals|Grant or research support-Vasa Therapeutics Inc.|Other relevant financial or material interests-Kiniksa Pharmaceuticals (*)

Amy Mueller, NP
Nurse Practitioner
Washington University
St. Louis, MO

Nurse Planner

Nothing to disclose

Heather L De Gortari, BS
Event Planner
Meeting Achievements
Hebron, IN

Other Planning Committee Member

Nothing to disclose

Edward M Geltman, MD
Professor of Medicine / Director Heart Failure Program at Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, MO

Other Planning Committee Member

Nothing to disclose

Polly Rossi, BS,
Meeting Achievements
Hebron, IN

Other Planning Committee Member

Nothing to disclose

Justin M. Vader, MD, FACC, FHFSA
Professor of Medicine, Cardiovascular Division
WashU Medicine
St. Louis, MO

Other Planning Committee Member

Grant or research support-Ancora Heart Inc|Grant or research support-Cytokinetics Inc|Grant or research support-Endotronix|Grant or research support-Novo Nordisk AS

Alan Zajarias, MD
Prof of Medicine
Washington University School of Medicine
St. Louis, MO

Other Planning Committee Member

Grant or research support-4C Medical Technologies|Grant or research support-Abbott Laboratories|Grant or research support-Edwards Lifesciences Corporation|Grant or research support-HeartFlow, Inc.|Grant or research support-JC Medical Inc.|Grant or research support-JenaValve Technology|Grant or research support-Medtronic Inc|Grant or research support-P&F USA Inc|Grant or research support-P+F Products + Features GmbH|Other relevant financial or material interests-Abbott Laboratories (*)|Other relevant financial or material interests-Admedus Biomanufacturing Pty Ltd (*)|Other relevant financial or material interests-Cath Lab Solutions LLC (*)|Other relevant financial or material interests-Edwards Lifesciences Corporation|Other relevant financial or material interests-Medtronic Inc (*)|Other relevant financial or material interests-Simulia (*)|Ownership-Tavrsolutions, LLC (*)|Royalties or Patent Beneficiary-Cath Lab Solutions LLC (*)|Stocks or stock options, excluding diversified mutual funds*-Admedus Biomanufacturing Pty Ltd (*)|Grant or research support-Protembis GmbH

Kent Botkin, PharmD
Advanced Heart Failure/Transplant Clinical Pharmacy Specialist
Barnes-Jewish Hospital
Saint Louis, MO

Pharmacy Planner

Nothing to disclose

Saturday, June 6, 2026